4.620
+0,65%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +198.3% | +228.1% | 3 / 3 | -3.1% | +2.51 pp | +1.66 pp | +2.6% | 1.67 | 13.18 | 3.251 | −3,1% | 94,4 | +127,3% | 13.18 | 12.94 | +1,8% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 4.620 (close price on 2026-10-19)EPS (TTM): 350,6
Financial charts
1.Revenue & growth
VND bn3.251Q2/26
1.Revenue & growth
VND bn3.251Q2/26
2.Profit & growth
VND bn52,9Q2/26
3.Profit mix (Penman)
VND bn352Q2/26
4.Margins & cost structure
%13.7%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn-599Q2/26
7.Asset structure
VND bn23.708Q2/26
8.Funding & debt health
VND bn · times23.708Q2/26
9.Revenue backlog
VND bn301Q2/26
10.Valuation
times · %13,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %130Q2/26
Adjusted EPS growth, latest quarter
198%
Average adjusted EPS growth, 3 quarters
316%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26